The carriers of pathogenic variants in MLH1 and MSH2 genes have a significantly higher risk of developing CRC at a younger age compared to carriers of pathogenic variants in MSH6 or PMS2 genes [19]. This evidence concerns the gene PMS2 and colorectal carcinoma.